Camurus

Board/Management Information • Nov 12, 2024

Camurus' Nomination Committee appointed for the Annual General Meeting 2025

Lund, Sweden — 12 November 2024 — Camurus today announced that the Nomination Committee for the Annual General Meeting (AGM), 2025 consists of the following persons, who together represent about 43 percent of the total number of shares and votes in Camurus based on the last known shareholder information:

• Per Sandberg, appointed by Sandberg Development AB,
• Arne Lööw, appointed by Fjärde AP-fonden,
• Oscar Bergman, appointed by Swedbank Robur Fonder, and
• Per Olof Wallström, Chairman of the Board of Camurus

The Nomination Committee's proposals will be presented in the Notice to the AGM 2025 and on Camurus' website, www.camurus.com.

Shareholders who wish to submit proposals to the Nomination Committee are welcome to contact the Nomination Committee at the company's address, Ideon Science Park, SE-223 70, Lund, Sweden. Proposals shall be submitted in due time before the AGM, but not later than 20 February 2025, to ensure that the proposals can be adequately considered by the Nomination Committee.

The AGM 2025 in Camurus will be held at 5:00 pm CET on 27 May 2025 in Lund. Shareholders who want to have a matter addressed at the AGM 2025 must submit such a proposal to the same address as above (subject "Annual General Meeting 2025") by 8 April 2025 at the latest.

About Camurus

Camurus is a Swedish, science-led biopharmaceutical company committed to developing and commercializing innovative, long-acting medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company's proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX. For more information, visit www.camurus.com.

For more information

Per Olof Wallström, Chairman of the Board Tel. +46 709 42 95 20 p.o.wallstrom@telia.com

The information was submitted for publication at 07:00 am CET on 12 November 2024.